Works by Je-Jung Lee

Results: 199
    1

    The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma.

    Published in:
    2009
    By:
    • Deok-Hwan Yang;
    • Jung-Joon Min;
    • Yong Jeong;
    • Jae-Sook Ahn;
    • Yeo-Kyeoung Kim;
    • Sang-Hee Cho;
    • Ik-Joo Chung;
    • Hee-Seung Bom;
    • Hyeoung-Joon Kim;
    • Je-Jung Lee;
    • Yang, Deok-Hwan;
    • Min, Jung-Joon;
    • Jeong, Yong Yeon;
    • Ahn, Jae-Sook;
    • Kim, Yeo-Kyeoung;
    • Cho, Sang-Hee;
    • Chung, Ik-Joo;
    • Bom, Hee-Seung;
    • Kim, Hyeoung-Joon;
    • Lee, Je-Jung
    Publication type:
    journal article
    2

    Chromosomal Rearrangements in 1,787 Cases of Acute Leukemia in Korea over 15 Years.

    Published in:
    Annals of Laboratory Medicine, 2025, v. 45, n. 4, p. 391, doi. 10.3343/alm.2024.0570
    By:
    • DongGeun Son;
    • Ho Cheol Jang;
    • Young Eun Lee;
    • Yong Jun Choi;
    • Joo Heon Park;
    • Ha Jin Lim;
    • Hyun-Jung Choi;
    • Hee Jo Baek;
    • Hoon Kook;
    • Mihee Kim;
    • Ga-Young Song;
    • Seo-Yeon Ahn;
    • Sung-Hoon Jung;
    • Deok-Hwan Yang;
    • Je-Jung Lee;
    • Hyeonug-Joon Kim;
    • Jae-Sook Ahn;
    • Myung-Geun Shin
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Clinical outcomes and prognostic factors inpatients with breast diffuse large B cell lymphoma;Consortium for Improving Survival of Lymphoma(CISL) study.

    Published in:
    BMC Cancer, 2010, v. 10, p. 321, doi. 10.1186/1471-2407-10-321
    By:
    • Ho-Young Yhim;
    • Hye Jin Kang;
    • Yoon Hee Choi;
    • Seok Jin Kim;
    • Won Seog Kim;
    • Yee Soo Chae;
    • Jin Seok Kim;
    • Chul Won Choi;
    • Sung Yong Oh;
    • Hyeon Seok Eom;
    • Jeong-A Kim;
    • Jae Hoon Lee;
    • Jong-Ho Won;
    • Hyeok Shim;
    • Je-Jung Lee;
    • Hwa Jung Sung;
    • Hyo Jung Kim;
    • Dae Ho Lee;
    • Cheolwon Suh;
    • Jae-Yong Kwak
    Publication type:
    Article
    9
    10
    11

    Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21.

    Published in:
    Cancer Immunology, Immunotherapy, 2022, v. 71, n. 3, p. 613, doi. 10.1007/s00262-021-02982-9
    By:
    • Thangaraj, Jaya Lakshmi;
    • Phan, Minh-Trang Thi;
    • Kweon, SoonHo;
    • Kim, Jinho;
    • Lee, Jong-Min;
    • Hwang, Ilwoong;
    • Park, Jeehun;
    • Doh, Junsang;
    • Lee, Seung-Hwan;
    • Vo, Manh-Cuong;
    • Chu, Tan-Huy;
    • Song, Ga-Young;
    • Ahn, Seo-Yeon;
    • Jung, Sung-Hoon;
    • Kim, Hyeoung-Joon;
    • Cho, Duck;
    • Lee, Je-Jung
    Publication type:
    Article
    12
    13
    14
    15
    16
    17

    Changes in Osteoblastic Activity in Patient Who Received Bortezomib as Second Line Treatment for Plasma Cell Myeloma: A Prospective Multicenter Study.

    Published in:
    BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/245247
    By:
    • Ki-Seong Eom;
    • Seok Jin Kim;
    • Je-Jung Lee;
    • Cheolwon Suh;
    • Jin Seok Kim;
    • Sung-Soo Yoon;
    • Byung Soo Kim;
    • Hye Jin Kang;
    • Young Jin Choi;
    • Chul Soo Kim;
    • Yang Soo Kim;
    • Jae-Yong Kwak;
    • Yoo Jin Kim;
    • Young Don Joo;
    • Yeung-Chul Mun;
    • Deog Yeon Jo;
    • Joon Seong Park;
    • Chi-Young Park;
    • Sung-Hyun Kim;
    • Chang-Ki Min
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS Study.

    Published in:
    Annals of Hematology, 2025, v. 104, n. 1, p. 515, doi. 10.1007/s00277-024-05958-8
    By:
    • Fu, Weijun;
    • Bang, Soo-Mee;
    • Huang, Honghui;
    • Kim, Kihyun;
    • Li, Wei;
    • An, Gang;
    • Lee, Je-Jung;
    • Cai, Zhen;
    • Jin, Jie;
    • Wang, Yafei;
    • Chim, Chor Sang;
    • Carson, Robin;
    • Liu, Rui;
    • Zhao, Man;
    • Chen, Xi;
    • Cui, Canchan;
    • Hou, Jian;
    • Wang, Jianxiang
    Publication type:
    Article
    27

    Correction to: Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS study.

    Published in:
    2024
    By:
    • Fu, Weijun;
    • Bang, Soo-Mee;
    • Huang, Honghui;
    • Kim, Kihyun;
    • Li, Wei;
    • An, Gang;
    • Lee, Je-Jung;
    • Cai, Zhen;
    • Jin, Jie;
    • Wang, Yafei;
    • Chim, Chor Sang;
    • Carson, Robin;
    • Liu, Rui;
    • Zhao, Man;
    • Chen, Xi;
    • Cui, Canchan;
    • Hou, Jian;
    • Wang, Jianxiang
    Publication type:
    Correction Notice
    28
    29

    Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015).

    Published in:
    Annals of Hematology, 2023, v. 102, n. 8, p. 2233, doi. 10.1007/s00277-023-05308-0
    By:
    • Kim, Mihee;
    • Lee, Je-Jung;
    • Min, Chang-Ki;
    • Lee, Ji Yun;
    • Jo, Jae-Cheol;
    • Yoon, Sung-Soo;
    • Lim, Sung-Nam;
    • Do, Young Rok;
    • Kim, Kihyun;
    • Lee, Jae Hoon;
    • Yoo, Kwai Han;
    • Bae, Sung Hwa;
    • Yi, Jun Ho;
    • Jung, Jongheon;
    • Eom, Hyeon-Seok;
    • Jung, Sung-Hoon
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 6, p. 446, doi. 10.1016/j.clml.2023.02.009
    By:
    • Fu, Weijun;
    • Bang, Soo-Mee;
    • Huang, Honghui;
    • Kim, Kihyun;
    • Li, Wei;
    • An, Gang;
    • Lee, Je-Jung;
    • Cai, Zhen;
    • Jin, Jie;
    • Wang, Yafei;
    • Lin, Tung-Liang;
    • Chim, Chor Sang;
    • Qi, Ming;
    • Wang, Jianping;
    • Lu, Xiaolin;
    • Song, Yang;
    • Jia, Bin;
    • Yang, Xue;
    • Liu, Wenyu;
    • Zhou, Tianyuan
    Publication type:
    Article
    40

    Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On 18F-FDG PET/CT at Baseline.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. 113, doi. 10.1016/j.clml.2021.08.012
    By:
    • Hee Jeong Cho;
    • Dong Won Baek;
    • Ju-Hyung Kim;
    • Jungmin Lee;
    • Yu Kyung Chung;
    • Sung-Hoon Jung;
    • Ga-young Song;
    • Seo-Yeon Ahn;
    • Jae-Sook Ahn;
    • Deok-Hwan Yang;
    • Je-Jung Lee;
    • Hyeoung-Joon Kim;
    • Chae Moon Hong;
    • Shin Young Jeong;
    • Jung-Joon Min;
    • Sang-Kyun Sohn;
    • Joon Ho Moon
    Publication type:
    Article
    41

    P-200: Pomalidomide-based chemotherapy in plasmacytoma at relapse.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S148, doi. 10.1016/S2152-2650(21)02327-2
    By:
    • Ji Hyun Lee;
    • Sung-Hyun Kim;
    • Kihyun Kim;
    • Chang-Ki Min;
    • Sung-Soo Park;
    • Sung-Soo Yoon;
    • Ja Min Byun;
    • Je-Jung Lee;
    • Sung-Hoon Jung;
    • Ho-Jin Shin;
    • Jae-Yong Kwak;
    • Ho-Young Yhim
    Publication type:
    Article
    42
    43
    44
    45
    46
    47

    A Prospective, Multicenter Phase II Study of Consolidation with Cyclophosphamide, Bortezomib and Dexamethasone (CVD) in Patients with Multiple Myeloma after Autologous Stem Cell Transplantation; The KMM130 Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e291, doi. 10.1016/j.clml.2019.09.478
    By:
    • Eom, Hyeon-Seok;
    • Jung, Jongheon;
    • Kim, Kihyun;
    • Min, Chang Ki;
    • Lee, Je-Jung;
    • Yoon, Sung-Soo;
    • Lee, Jae Hoon;
    • Kim, Jin Seok;
    • Shin, Ho-Jin;
    • Bang, Soo-Mee;
    • Sohn, Sang Kyun;
    • Suh, Cheolwon
    Publication type:
    Article
    48
    49
    50